Corrigendum to “Nrf2 deficiency aggravates the increase in osteoclastogenesis and bone loss induced by inorganic arsenic” [Toxicology and applied pharmacology 367 (2019) 62–70] (Toxicology and Applied Pharmacology (2019) 367 (62–70), (S0041008X19300523), (10.1016/j.taap.2019.02.003))

Zhiyuan Liu, Yongyong Hou, Lu Li, Yang Yang, Jingkun Jia, Zhixuan Hong, Tingfeng Li, Yuanyuan Xu, Jingqi Fu, Yongxin Sun, Masayuki Yamamoto, Huihui Wang, Jingbo Pi

Research output: Contribution to journalComment/debate

1 Citation (Scopus)

Abstract

The original version of this article contained an error in Fig. 5A. A representative figure of the NAC group was accidentally put into the NAC + iAs group in Nrf2-KD cells during the figure preparation stage. The error has been corrected in this version. The authors regret this error. (See Fig. 5.)

Original languageEnglish
Article number115801
JournalToxicology and Applied Pharmacology
Volume435
DOIs
Publication statusPublished - 2022 Jan 15

Fingerprint

Dive into the research topics of 'Corrigendum to “Nrf2 deficiency aggravates the increase in osteoclastogenesis and bone loss induced by inorganic arsenic” [Toxicology and applied pharmacology 367 (2019) 62–70] (Toxicology and Applied Pharmacology (2019) 367 (62–70), (S0041008X19300523), (10.1016/j.taap.2019.02.003))'. Together they form a unique fingerprint.

Cite this